FDA recall, , Moderate risk
Remel Campy CVA Medium
Campy CVA Medium may have low recovery of Campylobacter Jejuni.
Summary by Recall Canary from the FDA notice
What happened
Remel, Inc, of Lenexa, Kansas, recalled Campy CVA Medium 100/PK, R01272, after customer complaints reported low to no recovery of Campylobacter Jejuni ATCC 33291 on the identified lot. The recall began February 5, 2026, and was added to the FDA's Enforcement Report on February 26, 2026. The product was distributed in Arizona, Colorado, Illinois, New Jersey, Ohio, Tennessee and Washington.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is yours affected?
Match the UDI-DI and lot code listed under your product.
A UDI-DI is the device identifier printed with the barcode on the device label.
Campy CVA Medium 100/PK, R01272
- UDI-DI
- 848838001055
- Lot code
- R01272
- 339135
Recall details
- Company began the recall
- Sold in
US Nationwide distribution in the states of Arizona, Colorado, Illinois, New Jersey, Ohio, Tennessee, Washington.
- Company
- Remel, IncLenexa, Kansas
- Hazard
- Device defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98403
- Recall number
- Z-1474-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
In FDA's weekly enforcement report
Listed on Recall Canary
Summary updated
